Stocks · Health care · Biological Products, (No Diagnostic Substances)

REPLIGEN CORP

RGEN Clue Score51

United States Fiscal year ends December CIK 0000730272 Results filed 27 Oct 2026

Add to watchlist

What the insiders did Mostly scheduled

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$15.26M

$2.42M on a plan · $12.46M straight out of an exercise

Sold at will

$375.58K

2 of 25 sales

Net

−$15.26M

−$375.58K against sales at will